Company Reports (Pharma & Healthcare)


Company Reports (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Company Reports in the Pharma and healthcare gives a comprehensive coverage on a various company's activities in the medical field.

In the Pharma and Healthcare company reports, it gives information on various companies in healthcare industry.

The Company reports, gives information on these topics.

  • Current developmental pipeline and latest updates of pharmaceutical companies.
  • Business description
  • Key information and facts
  • Major projects accomplished
  • Company’s location and their subsidiaries
  • Market share analysis
  • Research and development
  • Competitor’s in Pharma and healthcare industry
  • Prospects of the company
  • Shareholders and latest news on company products.

List of top 12 fortune 500 Pharma companies worldwide given by CNN Money are Pfizer, Johnson & Johnson, Merck, Abbot Laboratories, Eli Lilly, Bristol-Myers Squibb, Amgen, Gilead Sciences, Mylan, Allergan, Biogen Idec, and Celgene. 

Publication Single User License (PDF) Price
Global Top 10 Medical Devices Companies: Company Guide

Global Top 10 Medical Devices Companies: Company Guide

Date Published: Feb 22 2015

Summary
The ICD Research Global Top 10 Medical Devices Companies: Company Guide is a crucial resource for anyone looking to gain information on the top companies in the global medical devices industry. Detailed company profile and SWOT analysis information is provided for all the leading companies who are ranked in order by total annual revenues generated.

$600.00
Horizon Pharma plc (HZNP) - Financial and Strategic SWOT Analysis Review

Horizon Pharma plc (HZNP) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 27 2015

Horizon Pharma plc (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

$300.00
Cigna-HealthSpring : Company Profile and SWOT Analysis

Cigna-HealthSpring : Company Profile and SWOT Analysis

Date Published: Jan 20 2015

This report is a crucial resource for industry executives and anyone looking to access key information about "Cigna-HealthSpring "

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

$125.00
Biolight AB (BIOL) - Financial and Strategic SWOT Analysis Review

Biolight AB (BIOL) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Livzon Pharmaceutical Group Inc. (000513) - Financial and Strategic SWOT Analysis Review

Livzon Pharmaceutical Group Inc. (000513) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Hansen Medical, Inc. (HNSN) - Financial and Strategic SWOT Analysis Review

Hansen Medical, Inc. (HNSN) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Merriman Holdings, Inc. (MERR) - Financial and Strategic SWOT Analysis Review

Merriman Holdings, Inc. (MERR) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
NeoStem, Inc. (NBS) - Financial and Strategic SWOT Analysis Review

NeoStem, Inc. (NBS) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review

AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

AcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company. The company develops and markets therapies for the treatment of acute and breakthrough pain. Its product pipeline includes Zalviso, ARX-02, ARX-03 and ARX-04. The company’s Zalviso has completed Phase 3 development. Its products in cancer breakthrough pain (ARX-02), procedural sedation (ARX-03), and acute trauma pain (ARX-04) have completed Phase 2 studies. The company’s NanoTab technology is a non-invasive, sublingual dosage form. AcelRx is headquartered in Redwood City, California, the US.

$300.00
ChoongAng Vaccine Laboratory (072020) - Financial and Strategic SWOT Analysis Review

ChoongAng Vaccine Laboratory (072020) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Team Health Holdings, Inc. (TMH) - Financial and Strategic SWOT Analysis Review

Team Health Holdings, Inc. (TMH) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

This comprehensive SWOT profile of Team Health Holdings, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

$300.00
Covalon Technologies Ltd. (COV) - Financial and Strategic SWOT Analysis Review

Covalon Technologies Ltd. (COV) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Scivanta Medical Corporation (SCVM) - Financial and Strategic SWOT Analysis Review

Scivanta Medical Corporation (SCVM) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

Scivanta Medical Corporation (Scivanta) is a medical device company. The company develops and offers products for medical procedures and treatments. Its cardiac monitoring system is a two-balloon esophageal catheter system, which is used to monitor cardiac performance. Scivanta acquires medical devices, pharmaceuticals and other proprietary technologies The company offers its services to cardiology, surgical and anesthesia markets. It markets products in the US and various countries around the world. Scivanta is headquartered in Spring Lake, New Jersey, the US.

$300.00
Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review

Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis Review

G&E Herbal Biotechnology Co., Ltd. (4911) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review

Prana Biotechnology Limited (PBT) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Litha Healthcare Group Limited (LHG) - Financial and Strategic SWOT Analysis Review

Litha Healthcare Group Limited (LHG) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
Sun Hing Vision Group Holdings Ltd. (125) - Financial and Strategic SWOT Analysis Review

Sun Hing Vision Group Holdings Ltd. (125) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

Sun Hing Vision Group Holdings Ltd. (Sun Hing) is an optical product manufacturer. The company designs, manufactures, and distributes eyewear. It offers optical frames including metal and plastic frames, sunglasses, and related products. The company specializes in developing, marketing and distributing eyewear for licensed brands in the Asian region. It company has a sales network all over the world. The company operates as a subsidiary of United Vision International Limited. Sun Hing is headquartered in Hong Kong.

$300.00
Regado Biosciences, Inc. (RGDO) - Financial and Strategic SWOT Analysis Review

Regado Biosciences, Inc. (RGDO) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00
DIO Corporation (039840) - Financial and Strategic SWOT Analysis Review

DIO Corporation (039840) - Financial and Strategic SWOT Analysis Review

Date Published: Jan 9 2015

Summary

$300.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data